Search results

At the WCC 10th Assembly in 2013, 19-year-old Shyreen Mvula captivated hundreds of people when she told her courageous story about how being born HIV-positive unfolded into a lifetime of struggling for justice.

The World Council of Churches - Ecumenical Advocacy Alliance applauds the first licensing agreement related to tuberculosis, announced on 25 January by the Medicines Patent Pool and Johns Hopkins University. The agreement will facilitate the clinical development of sutezolid, a tuberculosis drug candidate. The antibiotic sutezolid, in combination with other drugs, could be used to more effectively treat drug-sensitive and drug-resistant tuberculosis.

As we mark World AIDS Day 2015, the World Council of Churches-Ecumenical Advocacy Alliance (WCC-EAA) welcomes a license agreement between the Medicines Patent Pool (MPP) and Bristol Myers Squibb (BMS) for daclatasvir, an important direct acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus (HCV).